| Product NDC: | 17478-122 |
| Proprietary Name: | Clindamycin |
| Non Proprietary Name: | Clindamycin Phosphate |
| Active Ingredient(s): | 900 mg/50mL & nbsp; Clindamycin Phosphate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 17478-122 |
| Labeler Name: | Akorn, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA203048 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130405 |
| Package NDC: | 17478-122-50 |
| Package Description: | 1 BOTTLE, GLASS in 1 CARTON (17478-122-50) > 50 mL in 1 BOTTLE, GLASS |
| NDC Code | 17478-122-50 |
| Proprietary Name | Clindamycin |
| Package Description | 1 BOTTLE, GLASS in 1 CARTON (17478-122-50) > 50 mL in 1 BOTTLE, GLASS |
| Product NDC | 17478-122 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Clindamycin Phosphate |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20130405 |
| Marketing Category Name | ANDA |
| Labeler Name | Akorn, Inc. |
| Substance Name | CLINDAMYCIN PHOSPHATE |
| Strength Number | 900 |
| Strength Unit | mg/50mL |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |